Salarius Pharmaceuticals
SLRX
SLRX
11 hedge funds and large institutions have $104K invested in Salarius Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.12% more ownership
Funds ownership: 0.24% → 0.37% (+0.12%)
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$28K | |
| 2 | +$15K | |
| 3 | +$14.9K | |
| 4 |
Barclays
London,
United Kingdom
|
+$7K |
| 5 |
Citigroup
New York
|
+$5.28K |
Top Sellers
| 1 | -$14K | |
| 2 | -$11.6K | |
| 3 | -$5 | |
| 4 |
SS
SBI Securities
Tokyo,
Japan
|
-$1 |
| 5 |
BlackRock
New York
|
-$1 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HF
1
HRT Financial
New York
| $28K |
|
|||
2
UBS Group
Zurich,
Switzerland
| $16.3K |
|
|||
|
CSS
3
Cubist Systematic Strategies
Stamford,
Connecticut
| $15K |
|
|||
4
Goldman Sachs
New York
| $14.9K |
|
|||
5
Geode Capital Management
Boston,
Massachusetts
| $13.9K |
|
|||
|
6
Barclays
London,
United Kingdom
| $7K |
|
|||
|
7
Citigroup
New York
| $5.28K |
|
|||
|
TRCT
8
Tower Research Capital (TRC)
New York
| $3.28K |
|
|||
9
Osaic Holdings
Scottsdale,
Arizona
| $297 |
|
|||
|
MYIA
10
Mount Yale Investment Advisors
Denver,
Colorado
| $55 |
|
|||
11
Bank of America
Charlotte,
North Carolina
| $16 |
|
|||
12
Morgan Stanley
New York
| $6 |
|
|||
|
SS
13
SBI Securities
Tokyo,
Japan
| $1 |
|
|||
|
14
BlackRock
New York
| $1 |
|
|||
|
TSS
15
Two Sigma Securities
New York
| – |
|